ECSS
HALO icon

Eurizon Capital SGR SpA’s Halozyme HALO Stock Holding History

Eurizon Capital SGR SpA’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$241K Sell
3,121
-612
-16% -$41.7K ﹤0.01% 713
2026
Q1 		$234K Buy
3,733
+661
+22% +$46.6K ﹤0.01% 725
2025
Q4 		$208K Buy
+3,072
New +$207K ﹤0.01% 648

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Eurizon Capital SGR SpA's HALO Position: Q2 2026 in Review

Eurizon Capital SGR SpA reduced its Halozyme (HALO) stake by 16% in Q2 2026, selling an estimated $41.7K and leaving 3,121 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #713.

Eurizon Capital SGR SpA first reported a position in HALO in Q4 2025 and has held it in 3 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Eurizon Capital SGR SpA held 3,121 shares of Halozyme worth $241K as of Q2 2026.
  • Eurizon Capital SGR SpA sold 612 Halozyme shares in Q2 2026, an estimated $41.7K.
  • Halozyme made up ﹤0.01% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #713 holding.
  • Eurizon Capital SGR SpA first reported a position in Halozyme in Q4 2025 and has held it in 3 quarters since.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.